Accumulating evidence supports that embryonic transcription factors (Sox2, Oct4, Nanog) are present in melanoma CSCs where they work in concert to maintain cell stemness; moreover, their expression levels correlate with cell stemness features, such as pluripotency, tumor-initiating capacity and drug resistance [134,135,136,137,138,139]. Here, SOX2 is linked to melanoma.